These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3659897)

  • 21. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
    Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
    J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New method to quantitate platelets adhered on biomaterials using monoclonal antibodies to human platelet membrane glycoprotein SZ-21.
    Xi TF; Zhang JC; Tian WH; Wang CR; Lei XH; Wai HY; Ruan CG
    Biomater Artif Cells Artif Organs; 1990; 18(3):423-35. PubMed ID: 2383668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
    Danton MC; Zaleski A; Nichols WL; Olson JD
    J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of platelet activation inhibitors on the loss of glycoprotein Ib during storage of platelet concentrates.
    Bode AP; Knupp CL; Miller DT
    J Lab Clin Med; 1990 Jun; 115(6):669-79. PubMed ID: 2195129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
    Zucker MB; Puszkin EG; Sussman II; Mauss EA
    J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycoprotein Ib and glycoprotein IX are fully complexed in the intact platelet membrane.
    Du X; Beutler L; Ruan C; Castaldi PA; Berndt MC
    Blood; 1987 May; 69(5):1524-7. PubMed ID: 2436691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoinhibition of ristocetin-induced platelet aggregation.
    Nachman RL; Jaffe EA; Weksler BB
    J Clin Invest; 1977 Jan; 59(1):143-8. PubMed ID: 299747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Monoclonal antibody SZ-21 to platelet membrane glycoprotein IIIa].
    Ruan CG
    Zhonghua Yi Xue Za Zhi; 1987 Feb; 67(2):76-8. PubMed ID: 3109715
    [No Abstract]   [Full Text] [Related]  

  • 29. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
    Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
    Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trimucytin: a collagen-like aggregating inducer isolated from Trimeresurus mucrosquamatus snake venom.
    Teng CM; Ko FN; Tsai IH; Hung ML; Huang TF
    Thromb Haemost; 1993 Mar; 69(3):286-92. PubMed ID: 8470053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. von Willebrand factor binding to platelet GpIb initiates signals for platelet activation.
    Kroll MH; Harris TS; Moake JL; Handin RI; Schafer AI
    J Clin Invest; 1991 Nov; 88(5):1568-73. PubMed ID: 1939645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of cell surface molecules on human platelets with monoclonal antibodies. II. Diversity of antibody-binding sites on molecules and its relation to platelet function.
    Furukawa K; Hayashi K; Shiku H; Yamada K
    Acta Haematol; 1986; 75(3):147-52. PubMed ID: 2944344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An antiplatelet monoclonal antibody that inhibits ADP and epinephrine-induced aggregation.
    Vilella R; Lozano T; Mila J; Borche L; Ercilla G; Ordinas T; Vives J
    Thromb Haemost; 1984 Feb; 51(1):93-6. PubMed ID: 6232732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?
    Xu G; Ulrichts H; Vauterin S; De Meyer SF; Deckmyn H; Teng M; Niu L
    Toxicon; 2005 Apr; 45(5):561-70. PubMed ID: 15777951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Production and application of anti-human platelet GP IIb/IIIa monoclonal antibodies].
    Wu XW
    Zhonghua Yi Xue Za Zhi; 1989 Aug; 69(8):427-30, 30. PubMed ID: 2620270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlated measurement of platelet release and aggregation in whole blood.
    Ault KA; Rinder HM; Mitchell JG; Rinder CS; Lambrew CT; Hillman RS
    Cytometry; 1989 Jul; 10(4):448-55. PubMed ID: 2475308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
    Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D
    Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
    Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
    Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane proteins on human megakaryocytes and platelets identified by monoclonal antibodies.
    Thiagarajan P; Perussia B; De Marco L; Wells K; Trinchieri G
    Am J Hematol; 1983 May; 14(3):255-69. PubMed ID: 6846329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.